Tegaserod maleate
CAS: 189188-57-6
Ref. TM-T1551
10mg | 46.00 € | ||
25mg | 78.00 € | ||
50mg | 118.00 € | ||
100mg | 194.00 € | ||
200mg | 295.00 € | ||
500mg | 497.00 € | ||
1ml*10 (DMSO) | 50.00 € |
Product Information
- HTF-919, SDZ-HTF-919
- (2E)-2-[(5-methoxy-1H-indol-3-yl)methylidene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate (1:1)
- 2-[(5-Methoxy-1H-Indole-3-Yl)Methylene]-N-Pentylcarbazimidamide Hydrogen Maleate
- 2-[(Z)-(5-methoxy-3H-indol-3-ylidene)methyl]-N'-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate
- Htf 919
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (2Z)-2-butenedioate (1:1)
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (Z)-2-butenedioate (1:1)
- Sdz-Htf 919
- Tegaserod Maleate
- Tegaserod hydrogen maleate
- See more synonyms
- Tegaserode
- Tegibs 6
- Zelmac
- Zelnorm
Tegaserod maleate (SDZ-HTF-919) is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke.
Chemical properties
Technical inquiry about: TM-T1551 Tegaserod maleate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.